10x Genomics Inc (NASDAQ:TXG) traded at $12.31 at close of the session on Friday, February 14 and made an upward move of 3.14% on its previous day’s price.
Looking at the stock we see that its previous close was $11.94 and the beta (5Y monthly) reads 1.847 with the day’s price range being $11.865 – $13.07. In terms of its 52-week price range, TXG has a high of $51.22 and a low of $10.80. The company’s stock has lost about -17.79% over that past 30 days.
10x Genomics Inc has a market cap of $1.51 billion and is expected to release its quarterly earnings report in March.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 133.55M, with a low of 121.3M and a high of 147.9M. The median projection represents growth adding up to -5.29% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 612.62M, or 0.30% up from figures reported last year.
On the other hand, looking at the outlook for the TXG stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 8 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 5 have rated the 10x Genomics Inc (TXG) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -13.42% off its SMA20 and -16.44% from its 50-day simple moving average. The RSI (14) is pointing at 32.58 while the volatility over the past week is 10.07% and jumps to 7.05% over the past one month. The beta value is 1.89, while the average true range (ATR) is currently pointing at 1.06. The average price target for the stock over the next 12 months is $25, with the estimates having a low of $24 and a high of $46. These price ends are -94.96% and -273.68% off the current price level respectively, although investors could be excited at the prospect of a -103.09% if the TXG share price touches on the median price of $25.
Coming back to 10x Genomics Inc (NASDAQ:TXG), we note that the average 3-month trading volume was 2.15 million, while that of the preceding 10-day period stands at 3.63 million. Current shares outstanding are 108.24 million.
The insiders hold 17.25% of the company’s shares while institutions hold 79.42%. The data shows that short shares as of 2025-01-31, stood at 8.42 million at a short ratio of 4.41. This represents a 911.00 short interest in shares outstanding on 2025-01-31. Shares short rose in January from the previous month at 6.6 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -14.24% down in year-to-date price movement.
